SCHEMBL9865207

SCHEMBL9865207

O=C(NC(=NCCSc1ccc(Cl)cc1)NCCCc1c[nH]cn1)c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
NFKB1 P19838 1/20 0.37
NFKB2 Q00653 1/20 0.37
RELA Q04206 1/20 0.37
HRH4 Q9H3N8 4/20 0.37
RECQL P46063 1/20 0.36
HRH2 P25021 4/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
TDP1 Q9NUW8 1/20 0.36
SCN5A Q14524 1/20 0.36
SCN2A Q99250 1/20 0.36
ALDH1A1 P00352 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
HPGD P15428 1/20 0.36
CYP2C19 P33261 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10369688 0.96 HRH4 (0.38) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
SCHEMBL10369687 0.94 TDP1 (0.39) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
SCHEMBL10369686 0.94 TDP1 (0.39) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
SCHEMBL9867435 0.94 NPC1 (0.42) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
SCHEMBL9866763 0.94 NPC1 (0.42) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
SCHEMBL9865202 0.93 HRH4 (0.43) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
SCHEMBL9866047 0.93 HRH4 (0.43) NPC1RAB9ASMN1; SMN2NFKB1NFKB2
SCHEMBL9865721 0.91 HPGD (0.47) NPC1RAB9ASMN1; SMN2HRH4RECQL
SCHEMBL9865726 0.91 HPGD (0.47) NPC1RAB9ASMN1; SMN2HRH4RECQL
SCHEMBL9866485 0.89 HRH4 (0.42) NPC1RAB9ASMN1; SMN2NFKB1NFKB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5021431-A H-1 antagonist, h-2 agonist for treating hypertension, cardiac disease or arterial occlusion HEUMANN PHARMA GMBH & CO. (DE) 1991-06-04 US disclosed
EP-0199845-B1 IMIDAZOLYLALKYLGUANIDIN DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM HEUMANN PHARMA GMBH & CO (DE) 1990-08-01 EP disclosed
EP-0199845-A1 Imidazolylalkylguanidin derivatives, process for their preparation and pharmaceutical compositions containing them HEUMANN PHARMA GMBH & CO (DE) 1986-11-05 EP disclosed